InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Asia Pacific

  • Creating Asia’s IP hub

    Daren Tang, IPOS chief executive, answers Managing IP’s questions about IP reform in Singapore, the TPP and ASEAN

  • Courts get stricter in Australia and Singapore

    Paul Dewar of Davies Collison Cave Law Pty Ltd and Desmond Tan of Davies Collison Cave LLP provide overviews of the most important developments in IP in Australia and Singapore, including a series of important court decisions

  • The contentious monopoly

    Standard essential patents have long been a hot topic in China. Hou Guang and Jia Hongbo of Liu Shen & Associates explain the history and analyse recent developments

  • How to file trade marks in Japan

    Tomohiro Gyoda and Satoko Kubo of Shiga International Patent Office offer some tips to trade mark applicants to help them avoid costly office actions

  • Taxing software transactions

    Romeo H Duran of Sapalo Velez Bundang and Bulilan explains how transactions involving software are taxed in the Philippines


profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: SCOTUS TC Heartland v Kraft Foods Group Brands oral argument transcript is up! https://t.co/v29vEKCILp

Mar 27 2017 07:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

Likely to be an important question for some applicants, with UPC due to come into force in December this year https://t.co/ASuSYUpRqd

Mar 27 2017 04:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

Don't forget to sign up for our next webinar, on IP in Asia, this Thursday at 3pm (London) https://t.co/gh3Ka8t9q1 @inoviaIP @Minesoftnews

Mar 27 2017 04:38 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements